Indian Imatinib Exporters: Complete Supplier Ranking with Market Share — 224 Manufacturers (2026) — TransData Nexus

Q: Who is the largest imatinib supplier from India?

CIPLA LIMITED is the largest imatinib exporter from India with a 36.4% market share and export value of $10.6M.

Q: How many imatinib suppliers are there in India?

There are 224 active imatinib exporters in India, collectively shipping $29.3M worth of imatinib across 1,726 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top imatinib suppliers from India?

The top 5 imatinib suppliers from India — CIPLA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, JODAS EXPOIM PRIVATE LIMITED, NATCO PHARMA LIMITED — together control 81.2% of total imatinib export value from India.

Suresh Sormare

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

Imatinib Suppliers from India (2026) — 224 Exporters, $29.3M Market | TransData Nexus | TransData Nexus

Who Exports Imatinib from India — 224 Suppliers Behind a $29.3M Market

India's imatinib export market is supplied by 224 active exporters who collectively shipped $29.3M across 1,726 shipments. CIPLA LIMITED leads with a 36.4% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 81.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Imatinib Suppliers & Exporters — 224 manufacturers, $29.3M export market, top destinations and formulations — Imatinib supplier data — 224 exporters · $29.3M market · 1,726 shipmentsTransData Nexus · Indian Customs Data

Top Imatinib Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading imatinib exporter from India, holding a 36.4% share of the $29.3M market across 1,726 shipments from 224 exporters. The top 5 suppliers — CIPLA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, JODAS EXPOIM PRIVATE LIMITED, NATCO PHARMA LIMITED — collectively control 81.2% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (36.4%), EUGIA PHARMA SPECIALITIES LIMITED (21.1%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (9.9%), JODAS EXPOIM PRIVATE LIMITED (9.4%), NATCO PHARMA LIMITED (4.5%).

Top Imatinib Exporters from India

Ranked by export value · 224 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Imatinib Exporters from India — Ranked by Export Value. 224 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Imatinib — Export Intelligence Video

Visual overview of India's imatinib supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's imatinib pharmaceutical supplier landscape — $29.3M in total trade, 224 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Imatinib exporters

Certification and compliance status for top Imatinib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Approved	Yes	Yes	Multiple	Cipla has received FDA approvals for various drugs and holds WHO-GMP and EU GMP
EUGIA PHARMA SPECIALITIES LIMITED	Approved	Yes	Yes	Multiple	Eugia Pharma has FDA approvals for several drugs and maintains WHO-GMP and EU GM
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	Multiple	Sun Pharma holds FDA approvals for various drugs and possesses WHO-GMP and EU GM
NATCO PHARMA LIMITED	Approved	Yes	Yes	Multiple	Natco Pharma has received FDA approvals and holds WHO-GMP and EU GMP certificati
INTAS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Intas Pharmaceuticals holds FDA approvals and maintains WHO-GMP and EU GMP certi
HETERO LABS LIMITED	Approved	Yes	Yes	Multiple	Hetero Labs has FDA approvals and holds WHO-GMP and EU GMP certifications.
DR REDDYS LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	Dr. Reddy's Laboratories holds FDA approvals and maintains WHO-GMP and EU GMP ce
MSN LABORATORIES PRIVATE LIMITED	Approved	Yes	Yes	Multiple	MSN Laboratories has FDA approvals and holds WHO-GMP and EU GMP certifications.
SUN PHARMACEUTICAL INDUSTRIES LTD	Approved	Yes	Yes	Multiple	Sun Pharmaceutical Industries Ltd holds FDA approvals and maintains WHO-GMP and

TransData Nexus reviewed the regulatory standing of 9 leading Imatinib exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Imatinib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Pharma City of India," is a central hub for pharmaceutical research, manufacturing, and exports. The city contributes nearly 40% of the country's bulk drug production and hosts over 2,000 pharmaceutical companies. Notable firms such as Dr. Reddy's Laboratories, Natco Pharma, and Aurobindo Pharma are headquartered here, significantly influencing the production and export of Imatinib. The presence of Genome Valley, a premier biotech cluster with world-class infrastructure, further bolsters Hyderabad's position as a leader in pharmaceutical innovation and manufacturing.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical industry, accounting for 33% of India's drug manufacturing and 28% of drug exports. This region is home to major companies like Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Ltd., and Zydus Cadila Healthcare Ltd., which are instrumental in the formulation and export of medications, including Imatinib. The state's commitment to pharmaceutical excellence is evident in its 130 USFDA-certified drug manufacturing facilities, underscoring its pivotal role in the global pharmaceutical supply chain.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Imatinib exporters from India

January 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's product portfolio and manufacturing capabilities, potentially increasing its Imatinib export capacity.

Impact: This acquisition is expected to enhance Sun Pharma's product portfolio and manufacturing capabilities, potentially increasing its Imatinib export capacity.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharma announced the acquisition of Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition may bolster Sun Pharma's oncology pipeline, potentially affecting its Imatinib production and export strategies.

Impact: This acquisition may bolster Sun Pharma's oncology pipeline, potentially affecting its Imatinib production and export strategies.

Common Questions — Imatinib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which imatinib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 103 recorded shipments worth $10.6M. EUGIA PHARMA SPECIALITIES LIMITED (82 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (72 shipments) are also established high-volume exporters.

Q How many imatinib manufacturers are there in India?

India has 224 active imatinib exporters with a combined export market of $29.3M across 1,726 shipments to 119 countries. The top 5 suppliers hold 81.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for imatinib from India?

Average FOB unit price: $16.53 per unit, ranging from $0.01 to $1869.22. Average shipment value: $17.0K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Imatinib

Imatinib

Who Exports Imatinib from India — 224 Suppliers Behind a $29.3M Market

Top Imatinib Exporters from India — Ranked by Export Value

Top Imatinib Exporters from India

Related Analysis

Need Details?

Imatinib — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Imatinib Suppliers from India

Q Which imatinib supplier from India is the most reliable for bulk orders?

Q How many imatinib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for imatinib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Cipla Limited — Cipla acquires Ivia Beaute's personal care brands

Analysis Methodology